Who is Brent V. Furse? - Biotech Executive Leader
| Brent V. Furse | Details |
|---|---|
| Full Name | Brent V. Furse |
| Occupation | Chief Executive Officer & President at Vero Biotech |
| Location | Atlanta, Georgia, United States |
| Industry | Biopharmaceuticals |
| Leadership Roles | Executive Vice President, Chief Operating Officer, Chief Commercial Officer, Vice President and General Manager Interventional Medicine, Vice President Surgery and Perioperative Care, Vice President of Sales and Marketing |
| Previous Companies | The Medicines Company, Centers for Disease Control and Prevention, Bristol-Myers Squibb, Schering Plough Corporation |
| Board Memberships | Anthera Pharmaceuticals, The Special Olympics, Salus Tele-health |
| Notable Product Involvement | Angiomax |
Early Career and Key Contributions
Brent V. Furse's professional journey in the biopharmaceutical industry is marked by significant leadership roles and contributions to healthcare innovation. Before his current role at Vero Biotech, Furse was a pivotal member of The Medicines Company's leadership team. The Medicines Company, known for its focus on advancing the treatment of critical care patients, was a pre-IPO company when Furse joined in 2000. During his tenure, he held various leadership positions, including Executive Vice President, Chief Operating Officer, Chief Commercial Officer, Vice President and General Manager Interventional Medicine, Vice President Surgery and Perioperative Care, and Vice President of Sales and Marketing. His efforts were instrumental in the launch and success of Angiomax, a flagship anticoagulant product.
Leadership at Vero Biotech
Since June 2016, Brent V. Furse has been leading Vero Biotech as the CEO and President. Vero Biotech, headquartered in Atlanta, Georgia, is dedicated to the design, development, and commercialization of next-generation products aimed at addressing the unmet medical needs of patients with pulmonary and cardiac diseases. Under Furse's leadership, the company has focused on innovative solutions in respiratory care, as evidenced by their involvement in the AARC 2023 Zenith Award, which recognizes excellence in this field.
Board Memberships and Volunteer Work
Furse's commitment to healthcare extends beyond his executive roles. He serves on the board of Anthera Pharmaceuticals, a biopharmaceutical company that has focused on serious diseases, including cystic fibrosis and lupus. His dedication to community service is reflected in his board memberships with The Special Olympics, an organization that provides sports opportunities for individuals with intellectual disabilities, and Salus Tele-health, which offers telemedicine solutions.
Industry Engagement and Recognition
Brent V. Furse is recognized in the industry for his strategic and collaborative approach, as evidenced by the recommendations from colleagues and his participation in professional groups such as "Professionals in the Pharmaceutical and Biotech Industry" and "Medical Device Development, Marketing And Sales". These engagements demonstrate his commitment to fostering growth and innovation in the healthcare sector.
In summary, Brent V. Furse's professional journey is characterized by his leadership in the biopharmaceutical industry, his strategic role in product launches and partnerships, and his dedication to improving patient care through innovative healthcare solutions.